Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function.
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology; D002166:Camptothecin / Q000494:pharmacology; D002460:Cell Line; D003609:Dactinomycin / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004448:Echinomycin / Q000494:pharmacology; D004996:Ethidium / Q000494:pharmacology; D006389:Hemagglutinins, Viral; D009980:Influenza A virus / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D009439:Neuraminidase / Q000096:biosynthesis; D009522:Newcastle disease virus / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D009621:Nogalamycin / Q000494:pharmacology; D008926:Plicamycin / Q000494:pharmacology; D011370:Proflavine / Q000494:pharmacology; D014764:Viral Proteins / Q000096:biosynthesis*; D014779:Virus Replication / Q000187:drug effects
D006389:Hemagglutinins, Viral; D014764:Viral Proteins; D003609:Dactinomycin; D004448:Echinomycin; D015112:4-Nitroquinoline-1-oxide; D011370:Proflavine; D009439:Neuraminidase; D004996:Ethidium; D009621:Nogalamycin; D008926:Plicamycin; D002166:Camptothecin; D003630:Daunorubicin